SCHEMBL12581017

SCHEMBL12581017

COC(Cc1ccc(N)cc1)C(C)=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRR Q9GZT4 4/20 0.42
PSAT1 Q9Y617 2/20 0.41
PPARG P37231 5/20 0.41
PPARA Q07869 5/20 0.41
PPARD Q03181 3/20 0.41
LDHA P00338 1/20 0.40
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
ESR1 P03372 1/20 0.39
ESR2 Q92731 1/20 0.39
SOAT1 P35610 1/20 0.38
CXCR1 P25024 1/20 0.37
CXCR2 P25025 1/20 0.37
CYP3A4 P08684 2/20 0.37
SLC7A5 Q01650 1/20 0.37
LMNA P02545 1/20 0.37
CYP1A2 P05177 1/20 0.37
MAOA P21397 1/20 0.37
ALDH1A1 P00352 1/20 0.36
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1368490 0.86 PPARA (0.55) SRRPSAT1PPARGPPARAPPARD
SCHEMBL720354 0.86 PPARA (0.55) SRRPSAT1PPARGPPARAPPARD
SCHEMBL720353 0.86 PPARA (0.55) SRRPSAT1PPARGPPARAPPARD
SCHEMBL16451001 0.84 ESR1 (0.45) SRRPSAT1PPARGPPARAPPARD
SCHEMBL16743963 0.84 ESR1 (0.56) PPARGPPARAPPARDLDHAESR1
SCHEMBL8091095 0.81 SRR (0.58) SRRPPARGPPARAPPARDSLC7A5
SCHEMBL12141661 0.81 SRR (0.58) SRRPPARGPPARAPPARDSLC7A5
SCHEMBL4085094 0.81 LMNA (0.49) SRRPSAT1PPARGPPARAPPARD
SCHEMBL4085093 0.81 LMNA (0.49) SRRPSAT1PPARGPPARAPPARD
SCHEMBL1104884 0.79 SRR (0.39) SRRPSAT1PPARGPPARAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110152225-A1 PPAR-Gamma Agonists for the Induction of Cationic Antimicrobial Peptide Expression as Immunoprotective Stimulants NOGRA PHARMA LIMITED (IE) 2011-06-23 US disclosed
US-20110152225-A1 PPAR-Gamma Agonists for the Induction of Cationic Antimicrobial Peptide Expression as Immunoprotective Stimulants NOGRA PHARMA LIMITED (IE) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152225-A1 PPAR-Gamma Agonists for the Induction of Cationic Antimicrobial Peptide Expression as Immunoprotective Stimulants PPARG, FABP2, PPARD SRR 1693/4885PSAT1 1213/4885PPARG 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.